Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
Clinical trial NCT05682378 · RECRUITING
Trial details
- NCT number
- NCT05682378
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2032-03-25
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.